ArticleNPJ Parkinson's disease2025

Phase II pilot randomized trial of zonisamide for disease modification in prodromal Lewy body disease.

Keita Hiraga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.